Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Domperidone in Treating Patients With Gastrointestinal Disorders [Phase 3]
A Phase 3 clinical trial evaluating domperidone for several gastrointestinal disorders is currently recruiting.
-
FDA approval · 2026-02-09FDA Approved: GIMOTI — Supplemental Application (Evoke Pharma, Inc.)
FDA approved a supplemental application for GIMOTI (metoclopramide hydrochloride) from Evoke Pharma, resulting in labeling updates approved …
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Co-Development and Validation of Colonic Symptom Pictograms for Young People
A University of Auckland project is developing and validating pictograms for colonic symptoms in young people. The study covers functional c…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Exploring the Effect of Aromatherapy [NA]
A Baptist Health South Florida-sponsored clinical trial is evaluating aromatherapy for anxiety, labor pain, and nausea/vomiting, with enroll…
-
FDA approval · 2025-10-23FDA Approved: ONDANSETRON — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for ondansetron hydrochloride (ONDANSETRON) by NorthStar Rx LLC under ANDA078776. This confirms appr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-09-16FDA Approved: ONDANSETRON — Supplemental Application (Qilu Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for ondansetron from Qilu Pharmaceutical Co., Ltd. under ANDA203711.
-
FDA approval · 2025-08-01FDA Approved: METOCLOPRAMIDE — Supplemental Application (Ipca Laboratories Limited)
The FDA approved a supplemental application for metoclopramide from Ipca Laboratories Limited, indicating an approved change to the ANDA.
-
FDA approval · 2025-01-22FDA Approved: PROCHLORPERAZINE EDISYLATE — Supplemental Application (FOSUN PHARMA USA INC)
FDA approved a supplemental application for Prochlorperazine Edisylate by Fosun Pharma USA Inc.
-
FDA approval · 2025-01-22FDA Approved: COMPRO — Supplemental Application (Padagis US LLC)
FDA approves a supplemental application for COMPRO (prochlorperazine) by Padagis US LLC.
-
FDA approval · 2025-01-22FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals, Inc.'s supplemental application for Prochlorperazine Maleate.
-
FDA approval · 2025-01-22FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved a supplemental application for Prochlorperazine Maleate from Jubilant Cadista Pharmaceuticals Inc., indicating an approval acti…
-
FDA approval · 2025-01-22FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA granted a supplemental approval for Prochlorperazine Maleate from Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2025-01-22FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Prochlorperazine maleate from Chartwell RX, LLC. The product is used to treat nausea and vom…
-
FDA approval · 2025-01-22FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (GLENMARK PHARMACEUTICALS INC., USA)
FDA approved a supplemental application for prochlorperazine maleate filed by Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2025-01-22FDA Approved: PROCHLORPERAZINE EDISYLATE — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for Prochlorperazine edisylate from Eugia US LLC. The approval pertains to a supplemental submission…
-
FDA approval · 2024-12-10FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Fresenius Kabi USA, LLC)
The FDA approved an original application for chlorpromazine hydrochloride from Fresenius Kabi USA, LLC, making this generic antipsychotic av…
-
FDA approval · 2024-11-18FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved chlorpromazine hydrochloride as a generic product under an original ANDA for Camber Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer [Phase 1]
Phase 1 study evaluating whether aprepitant alters the pharmacokinetics of cyclophosphamide in patients with breast cancer; provides PK inte…
-
FDA approval · 2024-10-04FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Piramal Critical Care Inc.)
FDA approved a generic chlorpromazine hydrochloride product (Original Application) from Piramal Critical Care Inc.
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial assessed whether glycopyrrolate reduces nausea and vomiting following ERCP; the study has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Efficacy of Three Antiemetics in Preventing Nausea and Vomiting [Phase 4]
Phase 4 trial update evaluating the efficacy of three antiemetics to prevent nausea and vomiting.
-
FDA approval · 2024-03-06FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Parenteral Medicines, Inc.)
FDA approved Teva Parenteral Medicines, Inc.'s supplemental application for metoclopramide (ANDA073135), approving changes to the approved p…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: the Efficacy and Safety of Ondansetron Oral Soluble Pellicles [Phase 3]
Phase 3 trial update on the efficacy and safety of ondansetron oral soluble pellicles for nausea and vomiting.
-
FDA approval · 2023-11-21FDA Approved: TRIMETHOBENZAMIDE HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original ANDA for trimethobenzamide hydrochloride, enabling a generic version by Heritage Pharmaceuticals (d/b/a Avet Pharma…
-
FDA approval · 2023-09-26FDA Approved: ONDANSETRON — Supplemental Application (Eugia US LLC)
FDA granted a supplemental approval for Ondansetron hydrochloride from Eugia US LLC, updating the status of this generic product. The action…